Skip to main content
. 2017 Feb 2;6(2):e004529. doi: 10.1161/JAHA.116.004529

Figure 2.

Figure 2

Survival free of sudden cardiac death (A) and heart failure–related death (B) in patients with HCM. According to the risk category of hsCRP, subjects in the high hsCRP group had lower sudden cardiac death and heart failure–related death‐free survival than in the patients with HCM. P‐values were calculated using the log‐rank test. HCM indicates hypertrophic cardiomyopathy; hsCRP, high‐sensitivity C‐reactive protein.